人工智能、健康与医疗保健的今天与明天:JAMA人工智能峰会报告
JAMA人工智能峰会讨论了健康与医疗保健人工智能的开发、评估、监管、推广和监测。峰会指出此类工具健康影响常未被量化,因评估极具挑战或非必需,部分因不受美国食品药品监督管理局监管;提出需在多利益相关方参与、测量工具开发、国家代表性数据基础设施和激励结构四方面取得进展。
要点
- 医疗人工智能工具类型广泛,包括临床工具、个人健康技术、医疗系统运营工具及混合工具。
- 许多工具已被广泛采用,尤其医学影像、移动健康、医疗业务运营和门诊记录等混合功能。
- 确保人工智能公平部署并改善健康结局,需在四个关键领域取得进展。
核心结论
- 人工智能将在未来数年颠覆医疗保健的各个环节,鉴于医疗保健存在诸多长期问题,这一颠覆是巨大机遇。
- 这一颠覆改善所有人健康的可能性,将在很大程度上取决于能否创建一个能够快速、高效、稳健且可推广地获取这些工具对健康影响知识的生态系统。
研究设计与样本
- JAMA人工智能峰会报告,讨论健康与医疗保健人工智能应如何开发、评估、监管、推广和监测。
主要发现
- 健康与医疗保健人工智能涵盖临床工具(如脓毒症警报或糖尿病视网膜病变筛查软件)、个人健康技术(如移动健康应用程序)、医疗系统改善业务运营的工具(如收入周期管理或排班)以及支持业务运营和临床活动的混合工具。
- 许多人工智能工具已被广泛采用,尤其在医学影像、移动健康、医疗保健业务运营和门诊记录等混合功能方面。
- 所有此类工具均可产生重要健康影响(有益或有害),但这些影响常未被量化,因为评估极具挑战或非必需,部分因许多工具不受美国食品药品监督管理局监管。
- 评估的主要挑战是工具效果高度依赖于人机界面、用户培训和使用环境。
- 许多努力制定了负责任使用人工智能的标准,但多数聚焦于安全性监测(如检测模型幻觉)或机构对各类过程指标的合规性,并未涉及有效性(即证明结局改善)。
关键数值与推荐
- 确保人工智能公平部署并以改善健康结局的方式实施,或若提高医疗保健提供效率则安全地实施,需在四个领域取得进展。
- 第一,需要在全产品生命周期内多利益相关方参与,包括终端用户与开发者在初始工具创建中更紧密合作,以及开发者、监管机构和医疗系统在工具部署评估中更紧密合作。
- 第二,应开发和推广用于评估和监测的测量工具,除现有监测和认证举措外,还需新方法和专业知识使医疗系统能够开展或参与快速、高效、稳健的有效性评估。
- 第三,创建国家代表性数据基础设施和学习环境,以支持生成关于人工智能工具在不同环境中健康影响的推广性知识。
- 第四,应促进激励结构,利用市场力量和政策杠杆推动这些变革。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Artificial intelligence (AI) is changing health and health care on an unprecedented scale. Though the potential benefits are massive, so are the risks. The JAMA Summit on AI discussed how health and health care AI should be developed, evaluated, regulated, disseminated, and monitored. OBSERVATIONS: Health and health care AI is wide-ranging, including clinical tools (eg, sepsis alerts or diabetic retinopathy screening software), technologies used by individuals with health concerns (eg, mobile health apps), tools used by health care systems to improve business operations (eg, revenue cycle management or scheduling), and hybrid tools supporting both business operations (eg, documentation and billing) and clinical activities (eg, suggesting diagnoses or treatment plans). Many AI tools are already widely adopted, especially for medical imaging, mobile health, health care business operations, and hybrid functions like scribing outpatient visits. All these tools can have important health effects (good or bad), but these effects are often not quantified because evaluations are extremely challenging or not required, in part because many are outside the US Food and Drug Administration's regulatory oversight. A major challenge in evaluation is that a tool's effects are highly dependent on the human-computer interface, user training, and setting in which the tool is used. Numerous efforts lay out standards for the responsible use of AI, but most focus on monitoring for safety (eg, detection of model hallucinations) or institutional compliance with various process measures, and do not address effectiveness (ie, demonstration of improved outcomes). Ensuring AI is deployed equitably and in a manner that improves health outcomes or, if improving efficiency of health care delivery, does so safely, requires progress in 4 areas. First, multistakeholder engagement throughout the total product life cycle is needed. This effort would include greater partnership of end users with developers in initial tool creation and greater partnership of developers, regulators, and health care systems in the evaluation of tools as they are deployed. Second, measurement tools for evaluation and monitoring should be developed and disseminated. Beyond proposed monitoring and certification initiatives, this will require new methods and expertise to allow health care systems to conduct or participate in rapid, efficient, and robust evaluations of effectiveness. The third priority is creation of a nationally representative data infrastructure and learning environment to support the generation of generalizable knowledge about health effects of AI tools across different settings. Fourth, an incentive structure should be promoted, using market forces and policy levers, to drive these changes. CONCLUSIONS AND RELEVANCE: AI will disrupt every part of health and health care delivery in the coming years. Given the many long-standing problems in health care, this disruption represents an incredible opportunity. However, the odds that this disruption will improve health for all will depend heavily on the creation of an ecosystem capable of rapid, efficient, robust, and generalizable knowledge about the consequences of these tools on health.
引用
- Angus DC, Khera R, Lieu T, et al. AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial Intelligence. JAMA. 2025. PMID: 41082366. doi:10.1001/jama.2025.18490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。